New drug for meth abuse passes first safety check in healthy people
NCT ID NCT06316973
First seen Nov 10, 2025 · Last updated May 19, 2026 · Updated 29 times
Summary
This early-stage study tested a single intravenous dose of CS-1103 in 32 healthy adults to see if it is safe and how the body processes it. The goal is to eventually treat methamphetamine abuse and overdose. No treatment was given for the condition itself; this trial only gathered safety and drug-level data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.